Global Cas Nuclease Market Growth (Status and Outlook) 2023-2029

Global Cas Nuclease Market Growth (Status and Outlook) 2023-2029

Product Code:464143

Published Date: Feb 08,2023

Pages: 101

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

LPI (LP Information)' newest research report, the “Cas Nuclease Industry Forecast” looks at past sales and reviews total world Cas Nuclease sales in 2022, providing a comprehensive analysis by region and market sector of projected Cas Nuclease sales for 2023 through 2029. With Cas Nuclease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cas Nuclease industry.

This Insight Report provides a comprehensive analysis of the global Cas Nuclease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cas Nuclease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cas Nuclease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cas Nuclease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cas Nuclease.

The global Cas Nuclease market size is projected to grow from US$ 143.4 million in 2022 to US$ 845.7 million in 2029; it is expected to grow at a CAGR of 28.9% from 2023 to 2029.

The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.

This report presents a comprehensive overview, market shares, and growth opportunities of Cas Nuclease market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Cas9
    Cas12
    Cas13
    Others

Segmentation by application
    Gene Editing Cell Line Construction
    Animal Models
    Bioagriculture
    Gene Therapy
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Thermo Fisher Scientific
    GenScript
    Integrated DNA Technologies, Inc.
    Aldevron
    Merck
    Horizon Discovery
    Agilent
    OriGene Technologies, Inc
    New England Biolabs
    NIPPON GENE CO., LTD.
    Novoprotein
    Applied Biological Materials Inc. (abm)